XNCR logo

Xencor (XNCR) Company Overview

Profile

Full Name:

Xencor, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 3, 2013

Indexes:

Not included

Website:

http://www.xencor.com

Description:

Xencor, Inc. is a biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibodies and other protein therapeutics for the treatment of serious diseases (oncology, autoimmune). Founded in 1997. The company's main laboratory and administrative facilities are located in Monrovia, California. Xencor, Inc.'s patent portfolio includes over 1000 issued patents and pending patent applications. To carry out most of its operations and development programs, Xencor, Inc. relies on third-party contractors and service providers. Manufacturing, testing, quality assurance, clinical monitoring, data management, and regulatory expertise are outsourced to third parties.

Key Details

Price

$14.63

Market Cap

$1.02 B(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$168.34 M(+2.28% YoY)

Annual EPS

-$2.08(-123.66% YoY)

PE Ratio

-

Annual ROE

-18.06%

Annual Debt To Equity

0.03

Beta

1.41

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 12, 24 Wells Fargo
Overweight
Dec 2, 24 Piper Sandler
Overweight
Nov 8, 24 BMO Capital
Outperform
Nov 7, 24 JP Morgan
Overweight
Sep 26, 24 RBC Capital
Outperform
Aug 6, 24 RBC Capital
Outperform
Aug 6, 24 BMO Capital
Outperform
Jul 31, 24 JP Morgan
Overweight
Jun 14, 24 Raymond James
Strong Buy
Jun 14, 24 RBC Capital
Outperform

Screeners with XNCR included

Growing Shares Outstanding
US stocks
Stocks with high beta
Stocks below SMA 200
Earnings this week
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$14.63
XNCR price is $14.63

Price All-time High

$53.88
XNCR price is currently -72.85% below its historical high of $53.88

Price Analysts Target

$34.00
XNCR price is currently -56.97% lower than the consensus analysts' forecast

Price Today Change

+0.21%
XNCR price is up +0.21% today

Price YTD Change

-36.45%
XNCR price is down -36.45% since January 1st

Price 3-Year Change

-53.73%
XNCR price is down -53.73% over the past 3 years

Market cap

Market Cap

$1.02 B
XNCR market capitalization is $1.02 billion

Market Cap 3-Year Change

-45.47%
XNCR market capitalization is down -45.47% over the past 3 years

Market Cap All-time High

$3.12 B
XNCR market capitalization is currently -67.17% below its historical high of $3.12 billion

Market Cap Sector Rank

74.63%
XNCR market capitalization is higher than 74.63% of companies in Healthcare sector

Technical

Beta

1.41
XNCR beta is 1.41

200-day SMA

$20.68
XNCR price is currently -29.27% below its 200-day simple moving average

14-day RSI

16.45
XNCR 14-day relative strength index is 16.45

30-day Relative Volume

0.85
XNCR 30-day relative volume is 0.85

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$168.34 M
XNCR annual revenue is $168.34 million

Annual Revenue Analysts Estimate

$61.23 M
XNCR annual revenue is currently +174.92% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+2.28%
XNCR annual revenue is up +2.28% year-on-year

Annual Revenue Sector Rank

63.1%
XNCR annual revenue is higher than 63.1% of companies in Healthcare sector

Profit

Annual Gross Profit

-
XNCR annual gross profit value is unknown

Annual Gross Margin

-
XNCR annual gross profit margin value is unknown

Annual Operating Profit

-$138.64 M
XNCR annual operating income is -$138.64 million

Annual Operating Margin

-82.36%
XNCR annual operating profit margin is -82.36%

Annual Net Income

-$126.09 M
XNCR annual net profit is -$126.09 million

Annual Net Margin

-74.90%
XNCR annual net profit margin is -74.90%

EPS

Annual EPS

-$2.08
XNCR annual earnings per share is -$2.08

Annual EPS Analysts Estimate

-$3.66
XNCR annual earnings per share is currently -43.23% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-123.66%
XNCR annual earnings per share is down -123.66% year-on-year

Annual EPS Sector Rank

41.75%
XNCR annual earnings per share is higher than 41.75% of companies in Healthcare sector

ROA & ROE

Annual ROA

-14.02%
XNCR annual return on assets is -14.02%

Annual ROE

-18.06%
XNCR annual return on equity is -18.06%

EBIT & EBITDA

Annual EBIT

-$138.64 M
XNCR annual earnings before interest & taxes is -$138.64 million

Annual EBITDA

-$127.14 M
XNCR annual EBITDA is -$127.14 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
XNCR price to earnings ratio value is unknown

PE Ratio Sector Rank

-
XNCR price to earnings ratio is unknown

PB Ratio

PB Ratio

1.41
XNCR price to book ratio is 1.41

PB Ratio Sector Rank

50.33%
XNCR price to book ratio is higher than 50.33% of companies in Healthcare sector

PS Ratio

PS Ratio

12.02
XNCR price to sales ratio is 12.02

PS Ratio Sector Rank

79.38%
XNCR price to sales ratio is higher than 79.38% of companies in Healthcare sector

Enterprise value

Enterprise Value

$1.08 B
XNCR enterprise value is $1.08 billion

Enterprise Value Sector Rank

75.6%
XNCR enterprise value is higher than 75.6% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.72
XNCR EV/EBITDA is -5.72

EV/EBITDA Sector Rank

20.63%
XNCR EV/EBITDA is higher than 20.63% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

7.36
XNCR annual current ratio is 7.36

Annual Quick Ratio

-
XNCR annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.03
XNCR annual debt to equity ratio is 0.03

Annual Interest Coverage Ratio

-
XNCR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
XNCR piotroski f-score value is unknown

Altman Z-Score

1.86
XNCR altman z-score is 1.86

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$952.69 M
XNCR annual total assets is $952.69 million

Annual Non Current Assets

$329.53 M
XNCR annual long term assets is $329.53 million

Annual Current Assets

$623.16 M
XNCR annual total current assets is $623.16 million

Annual Cash & Cash Equivalents

$53.79 M
XNCR annual cash & cash equivalents is $53.79 million

Equity

Annual Book Value

$668.80 M
XNCR annual book value is $668.80 million

Annual Working Capital

$538.45 M
XNCR annual working capital is $538.45 million

Liabilities

Annual Total Liabilities

$283.56 M
XNCR annual total liabilities is $283.56 million

Annual Total Long Term Liabilities

$198.85 M
XNCR annual total long term liabilities is $198.85 million

Annual Current Liabilities

$84.71 M
XNCR annual total current liabilities is $84.71 million

Annual Accounts Payable

$13.91 M
XNCR annual accounts payable is $13.91 million

Debt

Annual Total Debt

$83.43 M
XNCR annual total debt is $83.43 million

Annual Total Debt 1-Year Change

+39.91%
XNCR annual total debt is up +39.91% year-on-year

Annual Long Term Debt

$73.67 M
XNCR annual long term debt is $73.67 million

Annual Short Term Debt

$9.77 M
XNCR annual short term debt is $9.77 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$306.98 M
XNCR annual total expenses is $306.98 million

Annual Operating Expenses

$306.98 M
XNCR annual total operating expenses is $306.98 million

Annual Cost Of Goods Sold

-
XNCR annual cost of goods sold value is unknown

Annual SGA

$53.38 M
XNCR annual SGA is $53.38 million

Annual D&A

$11.50 M
XNCR annual depreciation & amortization is $11.50 million

Annual Interest Expense

-
XNCR annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$85.11 M
XNCR annual cash flow from operations is $85.11 million

Annual CFO 1-Year Change

+247.6%
XNCR annual cash flow from operations is up +247.6% year-on-year

Annual CFI

-$111.06 M
XNCR annual cash flow from investing activities is -$111.06 million

Annual CFI 1-Year Change

+7.23%
XNCR annual cash flow from investing activities is up +7.23% year-on-year

Annual CFF

$26.18 M
XNCR annual cash flow from financing activities is $26.18 million

Annual CFF 1-Year Change

+359.17%
XNCR annual cash flow from financing activities is up +359.17% year-on-year

Free CashFlow

Annual FCF

$63.86 M
XNCR annual free cash flow is $63.86 million

Annual FCF 1-Year Change

+437.54%
XNCR annual free cash flow is up +437.54% year-on-year

CAPEX

Annual CAPEX

$21.25 M
XNCR annual capital expenditures is $21.25 million

Annual CAPEX 1-Year Change

-51.04%
XNCR annual capital expenditures is down -51.04% year-on-year

Institutional Ownership

Similar stocks

ESTA logo
Establishment Labs Holdings (ESTA)
AMN logo
AMN Healthcare Services (AMN)
Indivior (INDV)
OCUL logo
Ocular Therapeutix (OCUL)
HROW logo
Harrow Health (HROW)
HSTM logo
HealthStream (HSTM)
ELVN logo
Enliven Therapeutics (ELVN)
AORT logo
Artivion (AORT)
REPL logo
Replimune (REPL)

FAQ

  • What is the ticker symbol for Xencor?
  • Does Xencor pay dividends?
  • What sector is Xencor in?
  • What industry is Xencor in?
  • What country is Xencor based in?
  • When did Xencor go public?
  • Is Xencor in the S&P 500?
  • Is Xencor in the NASDAQ 100?
  • Is Xencor in the Dow Jones?
  • When was Xencor's last earnings report?
  • When does Xencor report earnings?
  • Should I buy Xencor stock now?

What is the ticker symbol for Xencor?

The ticker symbol for Xencor is NASDAQ:XNCR

Does Xencor pay dividends?

No, Xencor does not pay dividends

What sector is Xencor in?

Xencor is in the Healthcare sector

What industry is Xencor in?

Xencor is in the Biotechnology industry

What country is Xencor based in?

Xencor is headquartered in United States

When did Xencor go public?

Xencor's initial public offering (IPO) was on December 3, 2013

Is Xencor in the S&P 500?

No, Xencor is not included in the S&P 500 index

Is Xencor in the NASDAQ 100?

No, Xencor is not included in the NASDAQ 100 index

Is Xencor in the Dow Jones?

No, Xencor is not included in the Dow Jones index

When was Xencor's last earnings report?

Xencor's most recent earnings report was on Nov 6, 2024

When does Xencor report earnings?

The next expected earnings date for Xencor is Feb 27, 2025

Should I buy Xencor stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions